We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Certain Trials May Be Exempt From Requirements for INDs
Certain Trials May Be Exempt From Requirements for INDs
October 27, 2010
Not every drug sponsor must apply for an investigational new drug (IND) to conduct human clinical trials, the FDA says in a draft guidance designed to clear up confusion and misperceptions about IND exemptions.